
Preclinical study to assess CAR-Treg cells for neuroinflammation
PolTREG has launched a preclinical study with CAR-Treg cells in a humanized mouse model of neuroinflammatory disease. The study will measure the safety and efficacy of the therapy and data is anticipated by March 2025. PolTREG’s CAR-Treg cells are manufactured using the same technology… Read More
